They found that some nasal inflammatory indicators including the number of polymorphonuclear leukocytes (PMNs), and concentrations of bradykinin and the vasoactive intestinal peptide (VIP) were significantly higher in patients with OSA than those without OSA. This evidence concerns the gene VIP and obstructive sleep apnea syndrome.